Fact sheet: Maviret (glecaprevir + pibrentasvir)
This fact sheet summarizes up-to-date information on Maviret. Maviret is a medication used to treat hepatitis C. It is approved in Canada for people with hepatitis C in the following situations: those with any genotype of the virus who have never taken direct-acting antiretroviral (DAA) medication those with any genotype of the virus who have […]
https://orders.catie.ca/wp-content/uploads/2018/05/50279.png
English Hepatitis C Treatment World Hepatitis Day
Fact sheet: Maviret (glecaprevir + pibrentasvir)
Overview
This fact sheet summarizes up-to-date information on Maviret. Maviret is a medication used to treat hepatitis C. It is approved in Canada for people with hepatitis C in the following situations:
- those with any genotype of the virus who have never taken direct-acting antiretroviral (DAA) medication
- those with any genotype of the virus who have taken DAA medication with a type of medicine called an NS5A inhibitor or an NS3/4A protease inhibitor (but not both types of medication) and who were not cured of the virus
Format : Fact sheet
Date of Publication : 2018 (revised in 2019)
Author : CATIE
Catalogue No. : ATI-50279
Availability :
In Stock
Language : English
Download : PDF
Related Resources
-
This client brochure is for people who use crystal meth or for anyone who would like more informa...
-
This client brochure is for people who use crystal meth or for anyone who would like more informa...
-
This resource is for anyone living with HIV. It is designed to help readers take care of their se...
-
This resource is for anyone living with HIV. It is designed to help readers take care of their se...
-
Health and wellness magazine for people living with HIV. In this issue: positive trans women; the...
Browse By
Category
Format
Language
Author